| 摘要 |
Provided herein are compounds of the formula (I): wherein A, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>4</SUB>, R<SUB>a</SUB> and R<SUB>b</SUB> are as those disclosed in the specification, as well as pharmaceutically acceptable salts thereof. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of obesity, hyperphagia, anxiety, depression and related disorders and diseases. |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;BERTHEL, STEVEN JOSEPH;ERICKSON, SHAWN DAVID;FOTOUHI, NADER;KESTER, ROBERT FRANCIS;KIM, KYUNGJIN;MISCHKE, STEVEN GREGORY;QIAN, YIMIN;THAKKAR, KSHITIJ CHHABILBHAI;TILLEY, JEFFERSON WRIGHT;WANG, HONG |
发明人 |
BERTHEL, STEVEN JOSEPH;ERICKSON, SHAWN DAVID;FOTOUHI, NADER;KESTER, ROBERT FRANCIS;KIM, KYUNGJIN;MISCHKE, STEVEN GREGORY;QIAN, YIMIN;THAKKAR, KSHITIJ CHHABILBHAI;TILLEY, JEFFERSON WRIGHT;WANG, HONG |
